ANGO vs EQR · rev $292.5M vs P/E 26, $26.37B cap
AngioDynamics Inc (ANGO) versus Equity Residential (EQR) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Equity Residential (EQR) is a reit - residential company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
EQR does not have a complete income-statement cache yet.
ANGO currently screens at market cap $378.5M. EQR currently screens at market cap $26.37B and trailing P/E 25.7.
Not investment advice. Open the ANGO and EQR stock pages for the full models.
Not investment advice.